Factors Related to Human Papillomavirus Positivity among Oral Cavity and Pharynx Cancers from Surveillance, Epidemiology and End Results (SEER) Program Data

被引:0
|
作者
Jordan, Kelsey H. [1 ,7 ]
Fisher, James L. [2 ,3 ,4 ]
Stephens, Julie A. [5 ]
Paskett, Electra D. [1 ,2 ,3 ,4 ,6 ]
机构
[1] Ohio State Univ, Comprehens Canc Ctr, Div Populat Sci, Columbus, OH 43210 USA
[2] Ohio State Univ, Coll Publ Hlth, Div Epidemiol, Columbus, OH 43210 USA
[3] Arthur G James Canc Hosp, Columbus, OH 43201 USA
[4] Richard J Solove Res Inst, Columbus, OH 43201 USA
[5] Ohio State Univ, Coll Med, Ctr Biostat, Dept Biomed Informat, Columbus, OH 43210 USA
[6] Ohio State Univ, Coll Med, Dept Internal Med, Div Canc Prevent & Control, Columbus, OH 43210 USA
[7] Ohio State Univ, Dept Emergency Med, Columbus, OH 43210 USA
关键词
SQUAMOUS-CELL CARCINOMA; OROPHARYNGEAL CANCER; SOCIOECONOMIC-STATUS; HPV STATUS; HEAD; VACCINATION; DISPARITIES; CALIFORNIA; BREAST;
D O I
10.1158/1055-9965.EPI-22-0774
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: As human papillomavirus positive (HPV+) oral cavity and pharynx cancer (OCPC) incidence increases significantly, our objective was to determine whether select-ed sociodemographic and clinical factors were associated with HPV+ OCPCs overall and by oropharyngeal and non-oropharyngeal sites. Methods: Surveillance, Epidemiology and End Results (SEER) Program data were used in this study. Specifically, univariate and logistic regression models were used to examine the relationships between HPV+ and HPV- OCPC cases and age, sex, race, eth-nicity, marital status, factors of neighborhood socioeconomic status (i.e., nSES/Yost index) and rurality/urbanity, first malignancy sta-tus, histology, reporting source, stage at diagnosis, and OCPC anatomic site. The same approach was used to identify risk factors for HPV positivity for oropharyngeal and non-oropharyngeal OCPCs separately. Results: In all OCPCs, cases that were male, <80 years old, lived in the four highest nSES categories, diagnosed with a non-"gum and other mouth" OCPC (ref = hypopharynx), not locally staged at diagnosis, and a first malignancy had higher odds of being HPV+. Cases that were American Indian/Alaska Native and Asian or Pacific Islander (ref = White), Spanish-Hispanic-Latino ethnicity, non-married/partnered, and not reported by a hospital/clinic had lower odds of being HPV+. Associations were maintained in oropharyngeal OCPCs and only age and race remained significant for non-oropharyngeal OCPCs. Conclusions: Sociodemographic and clinical differences in HPV+ and HPV- OCPC, overall and for (non)oropharyngeal, cases exist. Impact: Identification of OCPC and (non)oropharyngeal risk factors for HPV positivity may assist in discovering high-risk groups that should receive enhanced public health efforts to reduce the U.S. OCPC burden.
引用
收藏
页码:452 / 462
页数:11
相关论文
共 50 条
  • [31] Survival disparities among racial/ethnic groups of women with ovarian cancer: An update on data from the Surveillance, Epidemiology and End Results (SEER) registry
    Stenzel, Ashley E.
    Buas, Matthew F.
    Moysich, Kirsten B.
    CANCER EPIDEMIOLOGY, 2019, 62
  • [32] Squamous cell carcinoma of the penis - Evaluation of data from the surveillance, epidemiology, and end results program
    Rippentrop, JM
    Joslyn, SA
    Konety, BR
    CANCER, 2004, 101 (06) : 1357 - 1363
  • [33] Survival among patients with multiple myeloma in the US military health system compared to the Surveillance, Epidemiology, and End Results (SEER) program.
    Dew, Alexander
    Darmon, Sarah
    Lin, Jie
    Ware, Jason
    Roswarski, Joseph Lee
    Shriver, Craig D.
    Zhu, Kangmin
    Chiu, Alden Vincent
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [34] Insurance and survival among lung cancer patients: Comparison of the US military health system and the surveillance, epidemiology, and end results (SEER) program
    Lin, Jie
    Shriver, Craig
    Zhu, Kangmin
    CANCER RESEARCH, 2022, 82 (12)
  • [35] Survival Among Patients With Multiple Myeloma in the United States Military Health System Compared to the Surveillance, Epidemiology, and End Results (SEER) Program
    Dew, Alexander
    Lin, Jie
    Darmon, Sarah
    Roswarski, Joe
    Shriver, Craig
    Zhu, Kangmin
    Chiu, Alden
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 (11): : 789 - 795
  • [36] Comparison of Survival among Colon Cancer Patients in the US Military Health System and Patients in the Surveillance, Epidemiology, and End Results (SEER) Program
    Lin, Jie
    McGlynn, Katherine A.
    Shriver, Craig D.
    Zhu, Kangmin
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2021, 30 (07) : 1359 - 1365
  • [37] Disparities by Race, Age, and Sex in the Improvement of Survival for Major Cancers Results From the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) Program in the United States, 1990 to 2010
    Zeng, Chenjie
    Wen, Wanqing
    Morgans, Alicia K.
    Pao, William
    Shu, Xiao-Ou
    Zheng, Wei
    JAMA ONCOLOGY, 2015, 1 (01) : 88 - 96
  • [38] Pancreatic cancer incidence trends: evidence from the Surveillance, Epidemiology and End Results (SEER) population-based data
    Gordon-Dseagu, Vanessa L.
    Devesa, Susan S.
    Goggins, Michael
    Stolzenberg-Solomon, Rachael
    INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2018, 47 (02) : 427 - 439
  • [39] Malignant melanoma in the first three decades of life: A report from the US Surveillance, Epidemiology and End Results (SEER) Program.
    Pappo, A
    Ries, L
    Herzog, C
    Bleyer, A
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 724S - 724S
  • [40] Cardiovascular mortality among 76 864 survivors of childhood cancers in the United States: a report from the surveillance, epidemiology, and end-results program
    Uppal, Saurav
    Al-Kindi, Sadeer G.
    Oliveira, Guilherme H.
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2018, 19 (01) : 38 - 41